Page 30 - GTM-4-1
P. 30

Global Translational Medicine                                   Phytonanotherapy in cancer and diabetes care




            Table 3. Research of plant‑based NPs in diabetes and cancer treatment
            Disease    Plant used   NP        Mechanism of action            Research findings        References
                                    type
            Diabetes  Gymnema sylvestre  AuNPs  Enhances insulin secretion and   Improved glucose uptake in diabetic animal models  5,21,25
                                          glucose uptake
                   Momordica charantia  AgNPs  Inhibits alpha-glucosidase and   Reduced post-prandial glucose spikes in studies  5,21,25.
                                          improves insulin sensitivity
                   Moringa oleifera  AuNPs  Protects pancreatic beta cells and   Enhanced beta-cell survival and reduced oxidative   5,21,25
                                          enhances antioxidant action  stress in diabetic rats
            Cancer  Catharanthus roseus  AuNPs  Induces apoptosis in cancer cells   Selectively killed breast cancer cells in vitro  21,35,49,58
                                          through ROS generation
                   Curcuma longa   AuNPs  Enhances drug delivery to tumors   Enhanced tumor targeting and reduced systemic   21,35,49,58
                                          and reduces inflammation  toxicity
                   Azadirachta indica  AgNPs  Triggers mitochondrial dysfunction   Effective in lung and colon cancer models  21,35,49,58
                                          in cancer cells
            Abbreviations: AuNPs: Gold NPs; AgNPs: Silver NPs; NPs: Nanoparticles; ROS: Reactive oxygen species.

            popularity. These nanocarriers can encapsulate anticancer   5.1.4. Clinical research
            medications and gradually release them at the tumor site,   Some green NP-based cancer therapeutics have advanced
            therefore decreasing systemic toxicity.
                                                               to early-stage clinical studies. 35,36  The purpose of these trials
              Green NPs are increasingly being used in combination   is to evaluate the safety and efficacy of these innovative
            therapy for cancer treatment. They have the ability   medicines in human patients.
            to transport numerous therapeutic agents, such as
            chemotherapeutic medicines, immunotherapeutic, and   5.1.5. Considerations for biosafety and regulation
            gene therapies, thereby increasing the overall efficacy of   The biosafety and regulatory elements of green NPs have
            cancer treatments. 33                              also been assessed, guaranteeing that these medicines fulfill
              Green NPs with dual therapeutic and diagnostic   rigorous safety and quality criteria for clinical application. 36
            properties (theranostics) have appeared. These NPs can   While these new results are encouraging, it is crucial to
            be utilized to deliver targeted drugs while also providing   highlight that translating green NP-based cancer treatments
            imaging  contrast  for  enhanced  tumor visualization  and   from the laboratory to clinical practice may take many
            monitoring therapy response.                       years, with extensive testing required to verify their safety

            5.1.1. Targeted delivery                           and efficacy in humans. As a result, ongoing research and
                                                               clinical trials will play a crucial role in defining the future
            Advances in the functionalization of green NPs with   of cancer therapeutics based on green NPs. Table 4 shows
            targeting ligands  and  antibodies  have  enabled more   the most recent breakthroughs in this field, encompassing
            accurate and effective therapeutic payload delivery to   current scientific literature and clinical trial databases.
            cancer cells. This lowers off-target effects while improving
            treatment outcomes. 34                             6. Antidiabetic phytomedicine

            5.1.2. Immunomodulation                            The use of phytochemicals from medicinal plants in the
                                                               manufacture of gold and silver NPs (NPs) offers great
            Certain green NPs have immunomodulatory qualities   promise, notably in their role as possible antidiabetic
            that can be used to stimulate the body’s immune response   medicines. Medicinal  plants are  high  in  bioactive
            against cancer cells. This strategy offers promise when
            combined with immunotherapies.                     components such as polyphenols, flavonoids, terpenoids,
                                                               and alkaloids, all of which have antidiabetic characteristics.
            5.1.3. Green algae NPs                             The NP synthesis procedure is both sustainable and
                                                               environmentally friendly because it uses natural substances.
            Algae-based NPs have received attention due to
            their natural abundance and biocompatibility. Green   Gold  and silver NPs can  boost  the  bioavailability of
            NPs generated from algae are being investigated for   antidiabetic phytochemicals that are poorly water soluble.
            application in cancer therapy, including photothermal and   This  means that a  greater  proportion of  these  beneficial
            photodynamic therapies. 35                         substances will be absorbed by the body, perhaps leading


            Volume 4 Issue 1 (2025)                         22                              doi: 10.36922/gtm.5840
   25   26   27   28   29   30   31   32   33   34   35